CAR-T

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

CAR-T
Jun 30, 2025, 14:18 | Insight
Khushali Jhaveri: Fascinating New Biomarker?
Khushali Jhaveri, Assistant Professor of Medicine at IU Simon Comprehensive Cancer Center, shared a post…
Jun 30, 2025, 08:58 | Insight
Rahul Banerjee: Excellent News - FDA Eliminates REMS Across CAR-T Products for US Patients
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Jun 26, 2025, 09:16 | Blog
Fredrik Schjesvold: CAR-T for Myeloma is Now Approved in Sweden
Fredrik Schjesvold, Head of Oslo Myeloma Center at Oslo University Hospital, shared a post on…
Jun 22, 2025, 10:35 | Insight
Yan Leyfman Highlighted Science Study on In Vivo CAR-T Cell Generation for Cancer and Autoimmune Disease
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Breakthrough…
Jun 13, 2025, 08:36 | Insight
Nico Gagelmann: Highlights from EHA 2025 - Breakthroughs in ET, Myelofibrosis, MM, MDS, and BPDCN
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at the EBMT, shared…
Jun 7, 2025, 16:30 | Insight
Goutham Sunny: Breakthroughs in Targeted Cancer Therapies
Goutham Sunny, Former Resident Doctor at The Gujarat Cancer and Research Institute, shared key highlights…
May 29, 2025, 12:46 | Blog
Honoring World Blood Cancer Day 2025: A Global Call to Action and Hope
On World Blood Cancer Day (WBCD), observed annually on May 28, the global oncology community…
Apr 11, 2025, 07:21 | Blog
Rahul Banerjee: Who really needs 2nd-line CAR-T and how do we make it safer?
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Apr 8, 2025, 12:09 | Science
Yan Leyfman: Do Pulmonary Function Tests Predict CAR-T Outcomes?
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Do…
Apr 1, 2025, 09:47 | Science
Giulia Claire Giudice: Strategies for RCC patients progressing on ICIs
Giulia Claire Giudice, Medical Doctor at University Hospital of Parma, shared an article on X: "Newly…
Mar 10, 2025, 08:25 | Blog
Prerna Mewawalla: Real-world outcomes of sequential BCMA-directed therapy in Multiple Myeloma
Prerna Mewawalla, Associate Professor at Drexel University, shared a post on X: "My VuMedi presentation…
Mar 9, 2025, 03:47 | Science
Francisco Conesa Buendía: Next-Gen CAR-T - TranspoCART19
Francisco Conesa Buendía, Assistant in Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Feb 13, 2025, 07:37 | Blog
Rahul Banerjee: Excited to speak with ASTCT about what’s new at Tandem25
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, reshared a…
Jan 15, 2025, 14:01 | Science
Kai Rejeski: Delineating the prognostic significance of immune reconstitution in CAR-T recipients
Kai Rejeski, Research Fellow at Memorial Sloan Kettering Cancer Center, shared an article by Sophia…
Jan 6, 2025, 16:30 | Science
Rahul Banerjee: A good reminder by Danai Dima that talquetamab can be used before BCMA CAR-T
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Jan 4, 2025, 16:32 | Insight
John Simmerling: Amazing molecular animation video on an activated T-cell engaging with a diseased cell
John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…
Dec 24, 2024, 11:31 | Science
Breakthrough of solid tumor treatment: CAR-NK immunotherapy, review by Hung Trinh
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared an article by Wenkang…
Dec 19, 2024, 15:56 | Science
HBI0101 BCMA-directed CAR-T experience in AL amyloid, summarised by Ben Derman
Ben Derman, Assistant Professor at University of Chicago, shared an article by Eyal Lebel on…
Dec 11, 2024, 14:33 | Blog
Sabrina Hanna: Visiting Kite Pharma's CAR T-Cell Manufacturing Facility
Sabrina Hanna, Chief change officer at The Cancer Collaborative and Executive Director of Save Your…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Nov 14, 2024, 13:29 | Blog
Amol Akhade about the role of CAR-T in solid tumors
Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
Nov 11, 2024, 13:41 | Insight
Myeloma Paper of the Day, November 11th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Helpful review of mechanisms and…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Sep 9, 2024, 13:23 | Immune Oncology,Oncolibrary
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
When comparing immunotherapy vs chemotherapy, it's important to understand how these cancer treatments work differently.…
Aug 20, 2024, 14:29 | Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 20, 2024, 14:22 | Blog
Prashant Mehta: CAR-T Cares Symposium
Prashant Mehta, Senior Consultant and Assistant Professor in the Department of Medical Oncology/Hematology-Oncology and Bone…
Aug 14, 2024, 10:29 | Insight
Rahul Banerjee: They say not all MRD negativity in myeloma is created equal
Rahul Banerjee shared on X: "They say not all MRD negativity in myeloma is created…
Aug 4, 2024, 09:41 | Insight
Michael Jain: 5-year outcomes of standard-of-care Axicabtagene Ciloleucel in lymphoma patients
Michael Jain, Oncologist at Moffitt Cancer Center, shared on X: "What is important for long-term…
Jul 28, 2024, 13:30 | Blog
Rahul Banerjee: Looking forward to GDUHEM this weekend
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "Looking forward to discussing…
Jul 11, 2024, 10:12 | Blog
Shilpa Gupta: Stellar talk by Neeraj Agarwal on tremendous progress in mCRpC in Athens
Shilpa Gupta shared a post on X: “Stellar talk by Neeraj Agarwal on tremendous progress…
Jul 1, 2024, 15:15 | Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jun 21, 2024, 02:21 | Insight
Ross Firestone: Healthcare utilization in CAR T and bispecifics patients with Multiple Myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared on X: “Excited to…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 18, 2024, 04:43 | Blog
Ruben Mesa: Wonderful work by Nilanjan Ghosh at EHA2024
Ruben Mesa shared a post by Nilanjan Ghosh, Chair of Department of Hematologic Oncology and…
Jun 11, 2024, 12:10 | Blog
Michelle Kirschner: Sami Mansfield will speak about Exercise Oncology for the Cancer Survivorship Provider Network
Michelle Kirschner recently shared a post by Sami Mansfield, Founder of Cancer Wellness for Life,…
May 23, 2024, 13:06 | Drugs
Ajay Major: Outcomes for DLBCL in CR at time of CAR-T infusion from CIBMTR
Ajay Major, Assistant Professor at the University of Colorado School of Medicine, recently shared a…
May 22, 2024, 06:44 | Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
May 21, 2024, 13:21 | Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
Apr 30, 2024, 06:00 | Blog
Mehdi Hamadani: The story of my CAR-T patient as painted by her continues
Mehdi Hamadani, Director of the BMT and Cellular Therapy Program at the Medical College of Wisconsin,…
Apr 29, 2024, 17:36 | Blog
Kate Cwynarski: Fantastic talk by Marco Ruella on CAR-T
Kate Cwynarski, Consultant Haematologist at University College London Hospitals NHS Foundation Trust, recently shared on…
Apr 27, 2024, 12:57 | Blog
Matteo Morotti: The results of our study on the effect of prostaglandin E2 on T cells
Matteo Morotti, Medical program leader at CDR-Life, shared on X/Twitter: "Proud to share the results…
Apr 26, 2024, 11:17 | Insight
Satya Prakash Yadav: Europe in 2022 BMT and Cell Therapy trends
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared on…
Apr 11, 2024, 14:45 | Insight
Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 7, 2024, 07:20 | Insight
Wafik El-Deiry: Dr. Alice Shaw speaks about directions in ADC’s in cancer therapy at AACR 2024
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Mar 18, 2024, 09:48 | Insight
Wafik S. El-Deiry: Important preliminary signal of transient response in GBM with CAR-T cells
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared a post…
Feb 5, 2024, 11:23 | Insight
Vinay Prasad: We estimate how many people are eligible for CAR-T
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 13, 2024, 14:53 | Blog
Spencer Knight: In vivo CART-T landscape
Spencer Knight, Senior Business Consultant of Cell and Gene Therapy at Charlton Morris, shared a…
Dec 31, 2023, 12:01 | Blog
Manni Mohyuddin: Context matters
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Dec 14, 2023, 16:06 | Blog
Nitin Jain: Wonderful to celebrate India’s CD19 CAR T approval
Nitin Jain, the Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Dec 14, 2023, 15:41 | Insight
Samer Al Hadidi: Will use of CAR-T earlier be better?
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X/Twitter:…
Dec 8, 2023, 12:40 | Insight
Amar Kelkar: We hope putting out independent cost-effectiveness analyses like this will encourage others to join
Amar Kelkar, Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard…
Oct 13, 2023, 17:15 | Drugs
Venkatraman Radhakrishnan: Inotuzumab take home points at SIOP 2023.
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute,…
Sep 20, 2023, 17:13 | Insight
Jeff Ryckman: How many patients make it to CAR-T without ever seeing radiotherapy?
Jeff Ryckman, Radiation Oncologist and Assistant Professor at West Virginia University shared a post by…
Sep 14, 2023, 02:57 | Insight
Michael Dickinson: In our article, we report on the development of rapid CART - YTB323, also known as rapcabtagene autoleucel.
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, recently shared on LinkedIn: "RAPID CAR-T! Autologous…
Sep 8, 2023, 19:03 | Insight
Angela Mastronuzzi: Our Ospedale Pediatrico Bambino Gesù team's recently published paper with Nature Communications by Nature Portfolio is out.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, recently posted on LinkedIn:…
All: 57 Posts: 1 - 100
Special Coverage